Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy: Lost, and Then Found, in Translation
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The hypothesis that renal nerves mediate, at least in part, the pathogenesis and maintenance of hypertension is based on decades of preclinical studies and, to a certain extent, recent clinical trials of catheter-based renal nerve ablation (CBRNA) in humans. The first 2 clinical trials for CBRNA, Symplicity HTN-1 and Symplicity HTN-2, reported sustained reductions in arterial pressure in patients with drug-resistant hypertension and set the stage for the first blinded US trial, Symplicity HTN-3. However, Symplicity HTN-3 failed to reach its 6-month efficacy end point, thus jeopardizing the clinical application of CBRNA in the United States. The goal of this article is to reexamine the feasibility of CBRNA to treat hypertension. Preclinical studies on the role of renal nerves in hypertension have been extensively reviewed,1,2 as have the Symplicity HTN-1, 2, and 3 trials.3–7 Therefore, we will review these topics only briefly to provide context for the primary purpose of this article which is to answer the following question: is the outcome of Symplicity HTN-3 because of the failure to translate preclinical knowledge to the clinic, or is our basic understanding of the mechanisms by which renal nerves contribute to hypertension flawed? The kidney is innervated by sympathetic efferent fibers that modulate 3 pharmacological targets for the treatment of hypertension: renin release, tubular sodium reabsorption, and renal vascular resistance.1,2 Although conventional pharmacological treatments of these targets lower arterial pressure, patients often present with negative side effects which may lead to drug incompliance. One rationale for CBRNA is that this treatment would suppress renin release, tubular sodium reabsorption, and renal vasoconstriction, while avoiding the side effects associated with more globally acting pharmacotherapies. The kidney is also innervated by renal afferent fibers that provide the central nervous system sensory information related to the …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Neural control of renal function
DiBona, G. F., & Kopp, U. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.1.75 · Cited by 1,212
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E., & Esler, M. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0904179 · Cited by 772 · cited 1×
“In 1 case report, multi-unit MSNA decreased from 56 bursts/min to 41 bursts/min 1 month after CBRNA and 19 bursts/min 12 months thereafter.(27) Another study did not find a reduction in MSNA after CBRNA, but they also did not observe a decrease in arterial pressure.”
Witkowski, A., Prejbisz, A., Florczak, E., Kądziela, J., Śliwiński, P., Bieleń, P., Michałowska, I., Kabat, M., Warchoł, E., Januszewicz, M., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.173799 · Cited by 460
Mahfoud, F., Cremers, B., Janker, J., Link, B., Vonend, O., Ukena, C., Linz, D., Schmieder, R., Rump, L. C., Kindermann, I., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.193870 · Cited by 303
Xiao, L., Kirabo, A., Wu, J., Saleh, M. A., Zhu, L., Wang, F., Takahashi, T., Loperena, R., Foss, J. D., Mernaugh, R. L., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306010 · Cited by 233 · cited 1×
“The same is true for the angiotensin II–induced mouse model in that RDN attenuates hypertension, but afferent renal nerve ablation does not.(22) When combined, these studies indicate the role of efferent and afferent nerves to the pathogenesis of hypertension are model dependent.”
Self-citationBrinkmann, J., Heusser, K., Schmidt, B. M., Menne, J., Klein, G., Bauersachs, J., Haller, H., Sweep, F. C., Diedrich, A., Jordan, J., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.201186 · Cited by 166
Banek, C. T., Knuepfer, M. M., Foss, J. D., Fiege, J. K., Asirvatham-Jeyaraj, N., Van Helden, D., Shimizu, Y., & Osborn, J. W. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07850 · Cited by 144
Self-citationHering, D., Marusic, P., Walton, A. S., Lambert, E. A., Krum, H., Narkiewicz, K., Lambert, G. W., Esler, M. D., & Schlaich, M. P. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.03098 · Cited by 142
Renal Nerves and Long‐Term Control of Arterial Pressure
Osborn, J. W., & Foss, J. D. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c150047 · Cited by 93 · cited 6×
“This is supported by animal studies showing that the extent of RDN and the fall in arterial pressure are linearly correlated.(1,33) A major limitation of CBRNA is the lack of a method to confirm completeness of denervation.”
InfluentialSelf-citation
Cited by
Function of Renal Nerves in Kidney Physiology and Pathophysiology
Osborn, J. W., Tyshynsky, R., & Vulchanova, L. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-091656 · Cited by 171
Self-citationWarchol-Celinska, E., Prejbisz, A., Kadziela, J., Florczak, E., Januszewicz, M., Michalowska, I., Dobrowolski, P., Kabat, M., Sliwinski, P., Klisiewicz, A., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11180 · Cited by 144
Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation
Mahfoud, F., Townsend, R. R., Kandzari, D. E., Kario, K., Schmieder, R. E., Tsioufis, K., Pocock, S., David, S., Patel, K., Rao, A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.044 · Cited by 115
Singh, R. R., McArdle, Z. M., Iudica, M., Easton, L. K., Booth, L. C., May, C. N., Parkington, H. C., Lombardo, P., Head, G. A., Lambert, G., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12250 · Cited by 86
Ong, J., Kinsman, B. J., Sved, A. F., Rush, B. M., Tan, R. J., Carattino, M. D., & Stocker, S. D. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00173.2019 · Cited by 76
Metadata
- Authors
- Osborn, J. W., & Banek, C. T.
- Venue
- Hypertension
- Published
- 2018-03
- Volume
- 71
- Issue
- 3
- Pages
- 383-388
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2782242012
- Cited by
- 49
- References
- 12
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy: Lost, and Then Found, in Translation. https://app.cochat.ai/papers/10.1161/hypertensionaha.117.08928
- The paper
- Osborn, J. W., & Banek, C. T. (2018). Catheter-Based Renal Nerve Ablation as a Novel Hypertension Therapy: Lost, and Then Found, in Translation. Hypertension. https://doi.org/10.1161/hypertensionaha.117.08928
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.